Literature DB >> 19214429

Host responses from innate to adaptive immunity after vaccination: molecular and cellular events.

Sang-Moo Kang1, Richard W Compans.   

Abstract

The availability of effective vaccines has had the most profound positive effect on improving the quality of public health by preventing infectious diseases. Despite many successful vaccines, there are still old and new emerging pathogens against which there is no vaccine available. A better understanding of how vaccines work for providing protection will help to improve current vaccines as well as to develop effective vaccines against pathogens for which we do not have a proper means to control. Recent studies have focused on innate immunity as the first line of host defense and its role in inducing adaptive immunity; such studies have been an intense area of research, which will reveal the immunological mechanisms how vaccines work for protection. Toll-like receptors (TLRs), a family of receptors for pathogen-associated molecular patterns on cells of the innate immune system, play a critical role in detecting and responding to microbial infections. Importantly, the innate immune system modulates the quantity and quality of longterm T and B cell memory and protective immune responses to pathogens. Limited studies suggest that vaccines which mimic natural infection and/or the structure of pathogens seem to be effective in inducing long-term protective immunity. A better understanding of the similarities and differences of the molecular and cellular events in host responses to vaccination and pathogen infection would enable the rationale for design of novel preventive measures against many challenging pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214429      PMCID: PMC6280669          DOI: 10.1007/s10059-009-0015-1

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  114 in total

1.  Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position.

Authors:  Karin Reif; Eric H Ekland; Lars Ohl; Hideki Nakano; Martin Lipp; Reinhold Förster; Jason G Cyster
Journal:  Nature       Date:  2002-03-07       Impact factor: 49.962

2.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

3.  The NS1 gene contributes to the virulence of H5N1 avian influenza viruses.

Authors:  Zejun Li; Yongping Jiang; Peirong Jiao; Aiqin Wang; Fengju Zhao; Guobin Tian; Xijun Wang; Kangzhen Yu; Zhigao Bu; Hualan Chen
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

4.  Divergent immunoglobulin g subclass activity through selective Fc receptor binding.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

5.  Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury.

Authors:  Bruce Cairns; Robert Maile; Carie M Barnes; Jeffrey A Frelinger; Anthony A Meyer
Journal:  J Trauma       Date:  2006-08

6.  Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.

Authors:  R H Carter; M O Spycher; Y C Ng; R Hoffman; D T Fearon
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

Review 7.  Learning from our foes: a novel vaccine concept for influenza virus.

Authors:  P Palese; T Muster; H Zheng; R O'Neill; A Garcia-Sastre
Journal:  Arch Virol Suppl       Date:  1999

8.  Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

Authors:  Hyun-Ku Lee; Stefan Dunzendorfer; Katrin Soldau; Peter S Tobias
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

9.  Protective T cell-independent antiviral antibody responses are dependent on complement.

Authors:  A F Ochsenbein; D D Pinschewer; B Odermatt; M C Carroll; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

10.  Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus.

Authors:  Koenraad F van der Sluijs; Leontine van Elden; Monique Nijhuis; Rob Schuurman; Sandrine Florquin; Henk M Jansen; René Lutter; Tom van der Poll
Journal:  Immunol Lett       Date:  2003-10-31       Impact factor: 3.685

View more
  17 in total

Review 1.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

2.  A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.

Authors:  Jason Gummow; Yanrui Li; Wenbo Yu; Tamsin Garrod; Danushka Wijesundara; Amelia J Brennan; Ranajoy Mullick; Ilia Voskoboinik; Branka Grubor-Bauk; Eric J Gowans
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

Review 3.  Mucosal immune responses to infection and vaccination in the respiratory tract.

Authors:  Robert C Mettelman; E Kaitlynn Allen; Paul G Thomas
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

Review 4.  Vaccines for the common cold.

Authors:  Daniel Simancas-Racines; Juan Va Franco; Claudia V Guerra; Maria L Felix; Ricardo Hidalgo; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

Review 5.  Virus-like particles as universal influenza vaccines.

Authors:  Sang-Moo Kang; Min-Chul Kim; Richard W Compans
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

6.  Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.

Authors:  Camila Mathias-Santos; Juliana F Rodrigues; Maria Elisabete Sbrogio-Almeida; Terry D Connell; Luís C S Ferreira
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

Review 7.  Systems biology applied to vaccine and immunotherapy development.

Authors:  Luigi Buonaguro; Ena Wang; Maria Lina Tornesello; Franco M Buonaguro; Francesco M Marincola
Journal:  BMC Syst Biol       Date:  2011-09-20

Review 8.  Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions.

Authors:  Ban Qi Tay; Quentin Wright; Rahul Ladwa; Christopher Perry; Graham Leggatt; Fiona Simpson; James W Wells; Benedict J Panizza; Ian H Frazer; Jazmina L G Cruz
Journal:  Vaccines (Basel)       Date:  2021-05-20

Review 9.  Use of Protamine in Nanopharmaceuticals-A Review.

Authors:  Ivana Ruseska; Katja Fresacher; Christina Petschacher; Andreas Zimmer
Journal:  Nanomaterials (Basel)       Date:  2021-06-07       Impact factor: 5.076

10.  H9N2 avian influenza virus in Korea: evolution and vaccination.

Authors:  Dong-Hun Lee; Chang-Seon Song
Journal:  Clin Exp Vaccine Res       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.